Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Growth

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 125.4238.82124.29-

What is the latest Core EBITDA Growth ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Growth ratio of TRIDENT LIFELINE is 125.42 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025125.42
Mar202438.82
Mar2023124.29
Mar2022-

How is Core EBITDA Growth of TRIDENT LIFELINE Trending?

Years Core EBITDA Growth % Change
Mar2025 125.42
223.08
Mar2024 38.82
-68.77
Mar2023 124.29
0
Mar2022 0 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Growth ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹297.6 Cr -1% -3.4% 1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-1%

-3.4%

1.4%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses